Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.97 |
| ▸ | MAPT | P10636 | 8/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.97 |
| ▸ | RECQL | P46063 | 7/20 | 0.97 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.97 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.97 |
| ▸ | XDH | P47989 | 7/20 | 0.97 |
| ▸ | FTO | Q9C0B1 | 7/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.97 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.97 |
| ▸ | APP | P05067 | 6/20 | 0.97 |
| ▸ | POLH | Q9Y253 | 6/20 | 0.97 |
| ▸ | POLB | P06746 | 5/20 | 0.97 |
| ▸ | TP53 | P04637 | 5/20 | 0.97 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL29353785 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL118425 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL31507620 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL19723 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL17629824 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29351036 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29723041 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL3786991 | 0.97 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL6756842 | 0.97 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL22103 | 0.97 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12195437-B2 | Lipophenolic flavonoid derivatives useful to reduce carbonyl and oxidative stresses (COS) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2025-01-14 | — | — | US | disclosed |
| CN-114196351-B | Aging-resistant lithium battery sealant and preparation method thereof | 江苏强劲新能源科技有限公司 | 2024-01-12 | — | — | CN | disclosed |
| EP-3820857-A1 | LIPOPHENOLIC FLAVONOID DERIVATIVES USEFUL TO REDUCE CARBONYL AND OXIDATIVE STRESSES (COS) | Centre National de la Recherche Scientifique (CNRS) (FR) | 2021-05-19 | — | — | EP | disclosed |
| US-20210139447-A1 | Lipophenolic Flavonoid Derivatives Useful To Reduce Carbonyl And Oxidative Stresses (COS) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2021-05-13 | — | — | US | disclosed |
| WO-2020012003-A1 | LIPOPHENOLIC FLAVONOID DERIVATIVES USEFUL TO REDUCE CARBONYL AND OXIDATIVE STRESSES (COS) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2020-01-16 | — | — | WO | disclosed |
| CN-107334761-A | Medical composition and its use | 中国科学院化学研究所 | 2017-11-10 | — | — | CN | disclosed |
| EP-2468741-A1 | Novel quercetin derivatives, their preparation, pharmaceutical compositions containing them and their use | Bel/Novamann International s.r.o. (SK) | 2012-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195437-B2 | Lipophenolic flavonoid derivatives useful to reduce carbonyl and oxidative stresses (COS) | LPO, NQO1, CAT | MEN1 3920/4885KMT2A 4226/4885CYP1A2 133/4885 |
| US-20210139447-A1 | Lipophenolic Flavonoid Derivatives Useful To Reduce Carbonyl And Oxidative Stresses (COS) | LPO, NQO1, CAT | MEN1 3920/4885KMT2A 4226/4885CYP1A2 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.